KIR3DL1 and acute lymphoblastic leukemia: Building on this, a subsequent study recommended that KIR genotyping be incorporated into donor selection algorithms for children with acute lymphoblastic leukemia undergoing haplo-HSCT, advocating for the preferential selection of KIR haplotype B donors with a high KIR B-content score whenever feasible [83].